Related Experiment Video
Updated: Nov 10, 2025
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Pancreatitis initiated pancreatic ductal adenocarcinoma: Pathophysiology explaining clinical evidence
Xufeng Tao1, Hong Xiang2, Yue Pan1
1Department of Pharmacology at School of Chemical Engineering, Dalian University of Technology, Dalian, China.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant lethal disease due to its asymptomatic at its early lesion of the disease and drug resistance. Target therapy associated with molecular pathways so far seems not to produce reasonable outcomes. Understanding of the molecular mechanisms underlying inflammation-initiated tumorigenesis may be helpful for development of an effective therapy of the disease. A line of studies showed that pancreatic tumorigenesis was resulted from pancreatitis, which was caused synergistically by various pancreatic cells. This review focuses on those players and their possible clinic implications, such as exocrine acinar cells, ductal cells, and various stromal cells, including pancreatic stellate cells (PSCs), macrophages, lymphocytes, neutrophils, mast cells, adipocytes and endothelial cells, working together with each other in an inflammation-mediated microenvironment governed by a myriad of cellular signaling networks towards PDAC.
Insights
Pancreatic ductal adenocarcinoma (PDAC) arises from pancreatitis, driven by complex cellular interactions within an inflammatory microenvironment. Understanding these inflammation-driven mechanisms is key to developing effective PDAC therapies.
Area of Science:
- Oncology
- Gastroenterology
- Cell Biology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with poor therapeutic outcomes.
- Early PDAC is often asymptomatic, and current targeted therapies show limited efficacy.
- Inflammation is increasingly recognized as a critical driver of PDAC development.
Purpose of the Study:
- To review the molecular mechanisms of inflammation-initiated pancreatic tumorigenesis.
- To identify key cellular players and their interactions in the PDAC microenvironment.
- To explore the clinical implications of understanding these inflammation-mediated pathways.
Main Methods:
- Literature review focusing on cellular and molecular mechanisms of PDAC.
- Analysis of studies linking pancreatitis to pancreatic cancer development.
- Examination of the roles of various pancreatic and stromal cells in tumorigenesis.
Main Results:
- Pancreatitis synergistically caused by various pancreatic cells can lead to PDAC.
- Multiple cell types, including acinar cells, ductal cells, and stromal cells (PSCs, macrophages, lymphocytes, neutrophils, mast cells, adipocytes, endothelial cells), contribute to PDAC.
- These cells interact within an inflammation-mediated microenvironment governed by complex signaling networks.
Conclusions:
- Understanding the interplay of cellular players in inflammation-driven PDAC is crucial.
- Targeting inflammation-mediated pathways and cellular interactions may offer novel therapeutic strategies for PDAC.
- Further research into these mechanisms could improve clinical outcomes for PDAC patients.
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...